Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-106b-5p ABCD2 2.81 0 -2.82 0.00416 MirTarget -0.5 2.0E-5 NA
2 hsa-miR-106b-5p ADAM19 2.81 0 0.44 0.52629 mirMAP -0.18 0.03423 NA
3 hsa-miR-106b-5p ADAM9 2.81 0 0.33 0.49553 miRNATAP -0.13 0.02564 NA
4 hsa-miR-106b-5p ADAMTS5 2.81 0 -6.22 0 miRNATAP -0.56 0 NA
5 hsa-miR-106b-5p ADRA2A 2.81 0 -3.42 0.00512 miRNATAP -0.75 0 NA
6 hsa-miR-106b-5p AHNAK 2.81 0 -1.19 0.03091 miRNATAP -0.28 2.0E-5 NA
7 hsa-miR-106b-5p AKAP11 2.81 0 -0.61 0.12508 miRNAWalker2 validate -0.19 5.0E-5 NA
8 hsa-miR-106b-5p AKAP13 2.81 0 -1.49 0.00023 MirTarget; mirMAP; miRNATAP -0.24 0 NA
9 hsa-miR-106b-5p AKT3 2.81 0 -3.33 1.0E-5 miRNATAP -0.41 1.0E-5 NA
10 hsa-miR-106b-5p ANK2 2.81 0 -5.41 0 MirTarget; miRNATAP -0.77 0 NA
11 hsa-miR-106b-5p ANKRD12 2.81 0 -0.49 0.18892 MirTarget -0.11 0.02006 NA
12 hsa-miR-106b-5p ANKRD29 2.81 0 -2.36 0.04103 MirTarget -0.35 0.01138 NA
13 hsa-miR-106b-5p ANKRD50 2.81 0 -0.02 0.97181 MirTarget; miRNATAP -0.2 0.00277 NA
14 hsa-miR-106b-5p ANO6 2.81 0 -1.42 0.00017 MirTarget -0.22 0 NA
15 hsa-miR-106b-5p APBB2 2.81 0 -1.53 0.00158 MirTarget; miRNATAP -0.12 0.0483 NA
16 hsa-miR-106b-5p AR 2.81 0 -4.57 0.00169 mirMAP -0.67 0.00014 NA
17 hsa-miR-106b-5p ARHGAP1 2.81 0 -0.85 0.00369 MirTarget; miRNATAP -0.18 0 NA
18 hsa-miR-106b-5p ARHGAP23 2.81 0 0.12 0.89085 mirMAP -0.35 0.00083 NA
19 hsa-miR-106b-5p ARHGEF3 2.81 0 -1 0.016 MirTarget; miRNATAP -0.16 0.00129 NA
20 hsa-miR-106b-5p ARID4A 2.81 0 -0.65 0.04997 MirTarget; miRNATAP -0.12 0.00297 NA
21 hsa-miR-106b-5p ASH1L 2.81 0 -0.25 0.53283 miRNATAP -0.1 0.03313 NA
22 hsa-miR-106b-5p ASPA 2.81 0 -5.53 0 mirMAP -0.57 7.0E-5 NA
23 hsa-miR-106b-5p ATP1A2 2.81 0 -6.92 0 MirTarget; miRNATAP -0.8 0 NA
24 hsa-miR-106b-5p BACH1 2.81 0 0.1 0.82342 mirMAP -0.17 0.00135 NA
25 hsa-miR-106b-5p BCAS1 2.81 0 -0.07 0.96835 mirMAP -0.48 0.0168 NA
26 hsa-miR-106b-5p BCL9L 2.81 0 -0.12 0.78985 mirMAP -0.17 0.00113 NA
27 hsa-miR-106b-5p BHLHE41 2.81 0 -1.22 0.21729 miRNATAP -0.45 0.00016 NA
28 hsa-miR-106b-5p BICD2 2.81 0 0.86 0.21413 MirTarget; miRNATAP -0.18 0.03129 NA
29 hsa-miR-106b-5p BMPR2 2.81 0 -1.13 0.00109 MirTarget; miRNATAP -0.12 0.00443 NA
30 hsa-miR-106b-5p BNC2 2.81 0 -6.04 0 miRNATAP -0.69 0 NA
31 hsa-miR-106b-5p BNIP3L 2.81 0 -0.64 0.09912 MirTarget -0.1 0.02447 NA
32 hsa-miR-106b-5p BTG2 2.81 0 -1.97 0.00034 miRNATAP -0.19 0.00464 NA
33 hsa-miR-106b-5p BTN3A3 2.81 0 -0.66 0.3546 miRNAWalker2 validate -0.2 0.01786 NA
34 hsa-miR-106b-5p C14orf28 2.81 0 -2.36 0 miRNATAP -0.24 0 NA
35 hsa-miR-106b-5p C3orf70 2.81 0 -3.41 0.0008 miRNATAP -0.44 0.00035 NA
36 hsa-miR-106b-5p CALD1 2.81 0 -3.83 0 miRNATAP -0.43 0 NA
37 hsa-miR-106b-5p CAMK2N1 2.81 0 -1.94 0.07697 miRNATAP -0.32 0.0156 NA
38 hsa-miR-106b-5p CAMK4 2.81 0 0.83 0.3952 mirMAP -0.25 0.03668 NA
39 hsa-miR-106b-5p CAPN5 2.81 0 -1.42 0.21891 mirMAP -0.32 0.02438 NA
40 hsa-miR-106b-5p CASC4 2.81 0 -1.31 0.00161 MirTarget -0.13 0.00793 NA
41 hsa-miR-106b-5p CAV1 2.81 0 -3.38 0.00041 miRNATAP -0.34 0.00331 NA
42 hsa-miR-106b-5p CAV2 2.81 0 -1.14 0.15869 mirMAP -0.22 0.02621 NA
43 hsa-miR-106b-5p CBX7 2.81 0 -3.22 0 mirMAP -0.25 8.0E-5 NA
44 hsa-miR-106b-5p CCBE1 2.81 0 -5.42 0.00228 mirMAP -0.45 0.0393 NA
45 hsa-miR-106b-5p CCND2 2.81 0 -2.81 0.0014 miRNAWalker2 validate; miRTarBase; miRNATAP -0.31 0.00374 NA
46 hsa-miR-106b-5p CCNG2 2.81 0 -0.75 0.10471 MirTarget; miRNATAP -0.14 0.01499 NA
47 hsa-miR-106b-5p CD28 2.81 0 0.13 0.8756 mirMAP -0.21 0.04267 NA
48 hsa-miR-106b-5p CD34 2.81 0 -4.42 0 miRNAWalker2 validate -0.36 0 NA
49 hsa-miR-106b-5p CD69 2.81 0 -0.72 0.42333 miRNATAP -0.41 0.00015 NA
50 hsa-miR-106b-5p CDKN1A 2.81 0 0.58 0.35758 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.17 0.02713 NA
51 hsa-miR-106b-5p CELF2 2.81 0 -2.48 0.00126 miRNATAP -0.32 0.00066 NA
52 hsa-miR-106b-5p CES2 2.81 0 0.44 0.44746 miRNAWalker2 validate -0.22 0.00153 NA
53 hsa-miR-106b-5p CHD9 2.81 0 -0.3 0.4758 MirTarget; miRNATAP -0.21 4.0E-5 NA
54 hsa-miR-106b-5p CLDN16 2.81 0 1.66 0.2236 mirMAP -0.39 0.01828 NA
55 hsa-miR-106b-5p CLIP4 2.81 0 -0.83 0.29386 MirTarget -0.27 0.00536 NA
56 hsa-miR-106b-5p CNTNAP3 2.81 0 0.85 0.50149 MirTarget -0.36 0.01812 NA
57 hsa-miR-106b-5p COL1A1 2.81 0 -1.84 0.04283 mirMAP -0.53 0 NA
58 hsa-miR-106b-5p COL8A2 2.81 0 -0.62 0.47257 mirMAP -0.49 0 NA
59 hsa-miR-106b-5p CORO2B 2.81 0 -3.89 0.0006 MirTarget; miRNATAP -0.52 0.00016 NA
60 hsa-miR-106b-5p CPEB3 2.81 0 -0.08 0.87798 miRNATAP -0.24 0.00011 NA
61 hsa-miR-106b-5p CPEB4 2.81 0 -0.65 0.23946 mirMAP -0.29 1.0E-5 NA
62 hsa-miR-106b-5p CRY2 2.81 0 -2.49 0 MirTarget; miRNATAP -0.17 1.0E-5 NA
63 hsa-miR-106b-5p CRYBG3 2.81 0 -0.15 0.82713 MirTarget; miRNATAP -0.22 0.00648 NA
64 hsa-miR-106b-5p CSF1 2.81 0 -1.1 0.12732 miRNATAP -0.26 0.00324 NA
65 hsa-miR-106b-5p CSGALNACT1 2.81 0 -1.68 0.01886 MirTarget -0.24 0.00646 NA
66 hsa-miR-106b-5p CTSK 2.81 0 -3.32 1.0E-5 MirTarget -0.74 0 NA
67 hsa-miR-106b-5p CXorf36 2.81 0 -4.77 0 mirMAP -0.5 0 NA
68 hsa-miR-106b-5p CYBRD1 2.81 0 -3.33 0 MirTarget -0.31 0.00023 NA
69 hsa-miR-106b-5p CYP2U1 2.81 0 -2.33 8.0E-5 MirTarget -0.18 0.01186 NA
70 hsa-miR-106b-5p DAB2 2.81 0 -2.28 0.00051 MirTarget; miRNATAP -0.37 0 26769181 The expression of the miR-106b target gene DAB2 in human cervical tissues and cell lines were measured by qRT-PCR western blot and immunohistochemistry; DAB2 a predicted target gene of miR-106b was inhibited by TGF-β1 partly through miR-106b and was involved in TGF-β1-induced cervical cancer cell migration; The expression of DAB2 was low in cervical cancer tissues and negatively correlated with miR-106b expression
71 hsa-miR-106b-5p DIP2C 2.81 0 -1.71 0.00051 miRNATAP -0.14 0.01701 NA
72 hsa-miR-106b-5p DIXDC1 2.81 0 -4.24 0 mirMAP -0.34 4.0E-5 NA
73 hsa-miR-106b-5p DLC1 2.81 0 -3.66 0 miRNATAP -0.52 0 26223867 MicroRNA 106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1; Moreover we identify DLC1 as a direct target of miR-106b reveal its expression to be inversely correlated with miR-106b in CRC samples and show that its re-introduction reverses miR-106b-induced CRC cell migration and invasion; Furthermore survival analyses showed the patients with high mi-106b/low DLC1 had shorter overall survival OS and disease-free survival DFS rates and confirmed miR-106b may be an independent prognostic factor for OS and DFS in CRC patients; Our findings indicate that miR-106b promotes CRC cell migration and invasion by targeting DLC1
74 hsa-miR-106b-5p DMD 2.81 0 -4.18 0.00037 mirMAP -0.42 0.00365 NA
75 hsa-miR-106b-5p DOCK4 2.81 0 -2.11 0.00043 MirTarget -0.16 0.0257 NA
76 hsa-miR-106b-5p DPYD 2.81 0 -0.3 0.70769 MirTarget -0.41 2.0E-5 NA
77 hsa-miR-106b-5p DSTYK 2.81 0 -0.94 0.00369 miRNATAP -0.11 0.0069 NA
78 hsa-miR-106b-5p EDA2R 2.81 0 -4.27 7.0E-5 MirTarget -0.52 7.0E-5 NA
79 hsa-miR-106b-5p EEA1 2.81 0 -0.24 0.59857 MirTarget; miRNATAP -0.25 1.0E-5 NA
80 hsa-miR-106b-5p EGR2 2.81 0 -1.39 0.09323 MirTarget; miRNATAP -0.33 0.0011 NA
81 hsa-miR-106b-5p ELAVL2 2.81 0 1.95 0.32272 MirTarget; miRNATAP -0.51 0.03133 NA
82 hsa-miR-106b-5p ELK3 2.81 0 -0.79 0.2934 miRNAWalker2 validate; MirTarget; miRNATAP -0.36 6.0E-5 NA
83 hsa-miR-106b-5p ENPP1 2.81 0 -5.25 1.0E-5 mirMAP -0.39 0.00587 NA
84 hsa-miR-106b-5p ENTPD1 2.81 0 -1.65 0 mirMAP -0.19 0 NA
85 hsa-miR-106b-5p EPB41L1 2.81 0 0.13 0.82668 mirMAP -0.23 0.00129 NA
86 hsa-miR-106b-5p EPHA4 2.81 0 -1.24 0.2429 miRNATAP -0.38 0.00333 NA
87 hsa-miR-106b-5p EPHA7 2.81 0 -3.77 0.02027 miRNATAP -0.4 0.04095 NA
88 hsa-miR-106b-5p ETV1 2.81 0 -1.44 0.12087 MirTarget; miRNATAP -0.43 0.00012 NA
89 hsa-miR-106b-5p EZH1 2.81 0 -1.8 0 MirTarget; miRNATAP -0.14 7.0E-5 NA
90 hsa-miR-106b-5p FAM102A 2.81 0 -0.08 0.85761 miRNATAP -0.16 0.00315 NA
91 hsa-miR-106b-5p FAT3 2.81 0 -3.48 0.01525 mirMAP -0.63 0.00026 NA
92 hsa-miR-106b-5p FAT4 2.81 0 -3.6 0.00012 MirTarget; miRNATAP -0.59 0 NA
93 hsa-miR-106b-5p FBXL3 2.81 0 -1.14 0.00089 miRNATAP -0.14 0.00054 NA
94 hsa-miR-106b-5p FBXL5 2.81 0 -0.86 0.00474 miRNATAP -0.11 0.00388 NA
95 hsa-miR-106b-5p FBXO3 2.81 0 -0.64 0.06434 mirMAP -0.13 0.00173 NA
96 hsa-miR-106b-5p FCHO2 2.81 0 -0.58 0.15656 miRNATAP -0.18 0.00022 NA
97 hsa-miR-106b-5p FGD5 2.81 0 -3.68 0 MirTarget; miRNATAP -0.45 0 NA
98 hsa-miR-106b-5p FGFR1 2.81 0 -3.68 0.00012 mirMAP -0.33 0.00494 NA
99 hsa-miR-106b-5p FGL2 2.81 0 -1.48 0.10265 MirTarget -0.39 0.00032 NA
100 hsa-miR-106b-5p FHL2 2.81 0 -1.28 0.09059 mirMAP -0.22 0.01819 NA
101 hsa-miR-106b-5p FIBIN 2.81 0 -3.85 0.00528 MirTarget -0.97 0 NA
102 hsa-miR-106b-5p FMN1 2.81 0 1.87 0.076 mirMAP -0.31 0.0155 NA
103 hsa-miR-106b-5p FNBP1 2.81 0 -2.26 0 miRNAWalker2 validate -0.17 0.0007 NA
104 hsa-miR-106b-5p FNDC3A 2.81 0 -1.17 0.01366 MirTarget; miRNATAP -0.15 0.00984 NA
105 hsa-miR-106b-5p FOXN3 2.81 0 -1.07 0.00864 miRNATAP -0.16 0.00104 NA
106 hsa-miR-106b-5p FRMD6 2.81 0 -1.61 0.08207 MirTarget; miRNATAP -0.43 0.0001 NA
107 hsa-miR-106b-5p FTO 2.81 0 -1.07 0.00045 mirMAP -0.11 0.00324 NA
108 hsa-miR-106b-5p FYCO1 2.81 0 -1.65 6.0E-5 MirTarget -0.22 1.0E-5 NA
109 hsa-miR-106b-5p FYN 2.81 0 -2.7 5.0E-5 miRNATAP -0.17 0.03506 NA
110 hsa-miR-106b-5p GAB1 2.81 0 -1.63 0.00014 MirTarget; miRNATAP -0.18 0.00042 NA
111 hsa-miR-106b-5p GAS7 2.81 0 -3.05 0.00021 mirMAP -0.61 0 NA
112 hsa-miR-106b-5p GBP4 2.81 0 0.55 0.60015 mirMAP -0.48 0.00014 NA
113 hsa-miR-106b-5p GCNT4 2.81 0 -0.7 0.43866 MirTarget -0.34 0.00167 NA
114 hsa-miR-106b-5p GFRA1 2.81 0 -6.72 0 mirMAP -1.12 0 NA
115 hsa-miR-106b-5p GNE 2.81 0 -1.11 0.12265 mirMAP -0.2 0.02358 NA
116 hsa-miR-106b-5p GPM6A 2.81 0 -8.84 0 miRNAWalker2 validate -0.74 0 NA
117 hsa-miR-106b-5p GPR137B 2.81 0 -0.66 0.11072 miRNATAP -0.17 0.00045 NA
118 hsa-miR-106b-5p GREM2 2.81 0 -5.65 0 mirMAP -0.69 0 NA
119 hsa-miR-106b-5p HAS2 2.81 0 -0.87 0.54181 MirTarget -0.42 0.01427 NA
120 hsa-miR-106b-5p HEG1 2.81 0 -1.11 0.15703 miRNATAP -0.49 0 NA
121 hsa-miR-106b-5p HLA-DOA 2.81 0 -1.19 0.28119 mirMAP -0.35 0.00821 NA
122 hsa-miR-106b-5p HLF 2.81 0 -4.18 0.00043 MirTarget; miRNATAP -0.45 0.00195 NA
123 hsa-miR-106b-5p IFNAR2 2.81 0 -0.05 0.87658 miRNAWalker2 validate -0.1 0.01118 NA
124 hsa-miR-106b-5p IKZF2 2.81 0 2.49 0.00195 mirMAP; miRNATAP -0.31 0.00125 NA
125 hsa-miR-106b-5p IKZF4 2.81 0 -1.11 0.00184 MirTarget; miRNATAP -0.11 0.00932 NA
126 hsa-miR-106b-5p IRF9 2.81 0 0.81 0.07531 miRNAWalker2 validate -0.13 0.01622 NA
127 hsa-miR-106b-5p ISM1 2.81 0 0.01 0.99522 miRNATAP -0.55 0 NA
128 hsa-miR-106b-5p JAK1 2.81 0 -0.61 0.04091 miRNAWalker2 validate; MirTarget -0.18 0 NA
129 hsa-miR-106b-5p JAM3 2.81 0 -4.56 0 mirMAP -0.53 0 NA
130 hsa-miR-106b-5p JAZF1 2.81 0 -3.33 0 MirTarget; miRNATAP -0.23 0.00186 NA
131 hsa-miR-106b-5p KANK1 2.81 0 -1.88 0.00218 mirMAP -0.3 5.0E-5 NA
132 hsa-miR-106b-5p KANK2 2.81 0 -3.73 0 miRNAWalker2 validate; mirMAP -0.36 0 NA
133 hsa-miR-106b-5p KAT2B 2.81 0 -1.07 0.03591 miRNAWalker2 validate; miRTarBase; MirTarget -0.28 1.0E-5 NA
134 hsa-miR-106b-5p KATNAL1 2.81 0 -1.63 0.00107 miRNAWalker2 validate; MirTarget -0.19 0.00183 NA
135 hsa-miR-106b-5p KCND3 2.81 0 -1.6 0.24861 mirMAP -0.82 0 NA
136 hsa-miR-106b-5p KCNE4 2.81 0 -4.84 0 miRNATAP -0.54 0 NA
137 hsa-miR-106b-5p KCNMA1 2.81 0 -6.35 0 miRNATAP -0.7 0 NA
138 hsa-miR-106b-5p KDSR 2.81 0 -0.72 0.0333 mirMAP -0.1 0.01237 NA
139 hsa-miR-106b-5p KIAA0355 2.81 0 -1.3 0.00011 mirMAP -0.12 0.00378 NA
140 hsa-miR-106b-5p KIAA0513 2.81 0 -0.31 0.60371 MirTarget; miRNATAP -0.22 0.0019 NA
141 hsa-miR-106b-5p KLF9 2.81 0 -3.7 0 MirTarget; miRNATAP -0.39 0 NA
142 hsa-miR-106b-5p KLHL20 2.81 0 -0.29 0.43362 MirTarget; miRNATAP -0.11 0.01766 NA
143 hsa-miR-106b-5p KLHL28 2.81 0 -0.13 0.76115 miRNATAP -0.12 0.01878 NA
144 hsa-miR-106b-5p KLHL3 2.81 0 -2.04 0.00444 mirMAP -0.18 0.03814 NA
145 hsa-miR-106b-5p KLHL6 2.81 0 0.99 0.19763 mirMAP -0.21 0.02308 NA
146 hsa-miR-106b-5p LAT2 2.81 0 0.48 0.42455 mirMAP -0.21 0.0036 NA
147 hsa-miR-106b-5p LDB3 2.81 0 -4.98 0 mirMAP -0.4 0.00038 NA
148 hsa-miR-106b-5p LMO3 2.81 0 -6.72 3.0E-5 MirTarget; miRNATAP -1.12 0 NA
149 hsa-miR-106b-5p LRFN5 2.81 0 -4.64 0.00014 miRNATAP -0.96 0 NA
150 hsa-miR-106b-5p LRRN4CL 2.81 0 -6 0 mirMAP -0.84 0 NA
NumGOOverlapSizeP ValueAdj. P Value
1 TISSUE DEVELOPMENT 67 1518 9.376e-13 4.363e-09
2 REGULATION OF CELL DIFFERENTIATION 64 1492 1.161e-11 2.702e-08
3 CARDIOVASCULAR SYSTEM DEVELOPMENT 41 788 3.716e-10 4.322e-07
4 CIRCULATORY SYSTEM DEVELOPMENT 41 788 3.716e-10 4.322e-07
5 INTRACELLULAR SIGNAL TRANSDUCTION 62 1572 7.786e-10 7.246e-07
6 MUSCLE STRUCTURE DEVELOPMENT 28 432 2.523e-09 1.957e-06
7 MUSCLE TISSUE DEVELOPMENT 22 275 3.075e-09 2.044e-06
8 CELL DEVELOPMENT 56 1426 6.954e-09 3.595e-06
9 REGULATION OF CELL DEVELOPMENT 40 836 6.79e-09 3.595e-06
10 REGULATION OF MAPK CASCADE 34 660 1.68e-08 7.106e-06
11 REGULATION OF PHOSPHORUS METABOLIC PROCESS 60 1618 1.53e-08 7.106e-06
12 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 61 1672 2.064e-08 8.005e-06
13 NEUROGENESIS 54 1402 2.598e-08 9.3e-06
14 REGULATION OF KINASE ACTIVITY 37 776 2.862e-08 9.511e-06
15 POSITIVE REGULATION OF CELL COMMUNICATION 57 1532 3.341e-08 1.036e-05
16 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 63 1784 3.894e-08 1.132e-05
17 REGULATION OF PROTEIN MODIFICATION PROCESS 61 1710 4.664e-08 1.276e-05
18 VASCULATURE DEVELOPMENT 27 469 5.836e-08 1.509e-05
19 POSITIVE REGULATION OF GENE EXPRESSION 61 1733 7.518e-08 1.522e-05
20 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 46 1135 7.402e-08 1.522e-05
21 NEURON DIFFERENTIATION 39 874 6.883e-08 1.522e-05
22 POSITIVE REGULATION OF CELL DEVELOPMENT 27 472 6.646e-08 1.522e-05
23 REGULATION OF CELLULAR COMPONENT MOVEMENT 36 771 7.523e-08 1.522e-05
24 REGULATION OF NEURON DIFFERENTIATION 29 554 1.429e-07 2.77e-05
25 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 58 1656 1.978e-07 3.681e-05
26 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 38 876 2.102e-07 3.762e-05
27 POSITIVE REGULATION OF MAPK CASCADE 26 470 2.251e-07 3.852e-05
28 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 45 1142 2.318e-07 3.852e-05
29 POSITIVE REGULATION OF RESPONSE TO STIMULUS 64 1929 2.898e-07 4.214e-05
30 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 42 1036 2.878e-07 4.214e-05
31 KIDNEY EPITHELIUM DEVELOPMENT 13 125 2.753e-07 4.214e-05
32 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 42 1036 2.878e-07 4.214e-05
33 UROGENITAL SYSTEM DEVELOPMENT 20 299 3.074e-07 4.334e-05
34 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 34 750 3.517e-07 4.813e-05
35 POSITIVE REGULATION OF KINASE ACTIVITY 26 482 3.655e-07 4.858e-05
36 BLOOD VESSEL MORPHOGENESIS 22 364 4.489e-07 5.803e-05
37 EPITHELIUM DEVELOPMENT 39 945 5.096e-07 6.409e-05
38 POSITIVE REGULATION OF MOLECULAR FUNCTION 60 1791 5.329e-07 6.525e-05
39 REGULATION OF ACTIN FILAMENT BASED PROCESS 20 312 6.034e-07 7.199e-05
40 HEART DEVELOPMENT 25 466 6.818e-07 7.931e-05
41 REGULATION OF SYSTEM PROCESS 26 507 9.504e-07 0.0001079
42 POSITIVE REGULATION OF CELL DIFFERENTIATION 35 823 1.035e-06 0.0001146
43 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 52 1492 1.086e-06 0.0001175
44 NEURON PROJECTION DEVELOPMENT 27 545 1.135e-06 0.00012
45 ACTIN FILAMENT BASED PROCESS 24 450 1.27e-06 0.0001313
46 REGULATION OF TRANSFERASE ACTIVITY 38 946 1.387e-06 0.0001403
47 ORGAN MORPHOGENESIS 35 841 1.69e-06 0.0001673
48 POSITIVE REGULATION OF CATALYTIC ACTIVITY 52 1518 1.809e-06 0.0001753
49 POSITIVE REGULATION OF NEURON DIFFERENTIATION 19 306 1.858e-06 0.0001764
50 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 32 740 2.171e-06 0.000202
51 NEURON PROJECTION MORPHOGENESIS 22 402 2.335e-06 0.0002131
52 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 16 229 2.703e-06 0.0002288
53 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 23 437 2.65e-06 0.0002288
54 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 5 14 2.689e-06 0.0002288
55 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 24 470 2.704e-06 0.0002288
56 REGULATION OF CHEMOTAXIS 14 180 3.296e-06 0.0002739
57 NEURON DEVELOPMENT 30 687 3.769e-06 0.0003024
58 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 15 208 3.764e-06 0.0003024
59 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 30 689 3.993e-06 0.0003149
60 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 48 1395 4.219e-06 0.0003218
61 MUSCLE CELL DIFFERENTIATION 16 237 4.208e-06 0.0003218
62 POSITIVE REGULATION OF LOCOMOTION 22 420 4.731e-06 0.0003551
63 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 13 162 5.245e-06 0.0003874
64 RESPONSE TO ENDOGENOUS STIMULUS 49 1450 5.429e-06 0.0003947
65 REGULATION OF CELL ADHESION 28 629 5.61e-06 0.0003955
66 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 38 1004 5.601e-06 0.0003955
67 CARDIAC MUSCLE TISSUE DEVELOPMENT 12 140 6.145e-06 0.0004267
68 EPITHELIAL CELL DIFFERENTIATION 24 495 6.527e-06 0.0004466
69 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 57 1805 6.669e-06 0.0004497
70 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 19 337 7.534e-06 0.0004869
71 CELLULAR COMPONENT MORPHOGENESIS 35 900 7.532e-06 0.0004869
72 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 20 368 7.484e-06 0.0004869
73 CELL PROJECTION ORGANIZATION 35 902 7.9e-06 0.0005036
74 REGULATION OF TRANSPORTER ACTIVITY 14 198 9.925e-06 0.0006198
75 MULTICELLULAR ORGANISMAL SIGNALING 11 123 9.99e-06 0.0006198
76 REGULATION OF NEURON PROJECTION DEVELOPMENT 21 408 1.017e-05 0.0006228
77 REGULATION OF CELL SUBSTRATE ADHESION 13 173 1.073e-05 0.0006482
78 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 27 616 1.094e-05 0.0006524
79 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 36 957 1.147e-05 0.000667
80 ENDOCHONDRAL BONE MORPHOGENESIS 7 45 1.147e-05 0.000667
81 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 24 513 1.182e-05 0.0006791
82 REGULATION OF MAP KINASE ACTIVITY 18 319 1.294e-05 0.0007344
83 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 15 232 1.407e-05 0.0007885
84 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 37 1008 1.477e-05 0.0008084
85 MUSCLE CELL DEVELOPMENT 11 128 1.461e-05 0.0008084
86 METANEPHRIC NEPHRON DEVELOPMENT 6 32 1.617e-05 0.000875
87 HEART PROCESS 9 85 1.659e-05 0.0008873
88 RESPONSE TO MECHANICAL STIMULUS 14 210 1.929e-05 0.00102
89 REGULATION OF JNK CASCADE 12 159 2.239e-05 0.00117
90 CIRCULATORY SYSTEM PROCESS 19 366 2.392e-05 0.001223
91 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 11 135 2.412e-05 0.001223
92 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 17 303 2.418e-05 0.001223
93 MUSCLE ORGAN DEVELOPMENT 16 277 2.947e-05 0.001474
94 NEPHRON DEVELOPMENT 10 115 3.227e-05 0.001589
95 PROTEIN AUTOPHOSPHORYLATION 13 192 3.245e-05 0.001589
96 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 34 926 3.322e-05 0.00161
97 DEVELOPMENTAL MATURATION 13 193 3.426e-05 0.001643
98 RESPONSE TO HORMONE 33 893 3.843e-05 0.00178
99 TUBE DEVELOPMENT 24 552 3.863e-05 0.00178
100 CARDIAC MUSCLE CELL ACTION POTENTIAL 6 37 3.856e-05 0.00178
101 REGULATION OF CELL MORPHOGENESIS 24 552 3.863e-05 0.00178
102 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 13 197 4.24e-05 0.001934
103 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 6 38 4.513e-05 0.002039
104 REGULATION OF CELL PROJECTION ORGANIZATION 24 558 4.581e-05 0.00205
105 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 18 352 4.756e-05 0.002108
106 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 42 1275 4.901e-05 0.002151
107 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 6 39 5.256e-05 0.002203
108 STRIATED MUSCLE CELL DIFFERENTIATION 12 173 5.143e-05 0.002203
109 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 39 1152 5.189e-05 0.002203
110 SKELETAL SYSTEM MORPHOGENESIS 13 201 5.218e-05 0.002203
111 REGULATION OF GTPASE ACTIVITY 27 673 5.109e-05 0.002203
112 ANGIOGENESIS 16 293 5.778e-05 0.0024
113 REGULATION OF TRANSMEMBRANE TRANSPORT 20 426 6.046e-05 0.002489
114 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 22 498 6.435e-05 0.002626
115 BONE MORPHOGENESIS 8 79 6.768e-05 0.002738
116 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 23 541 7.854e-05 0.003124
117 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 23 541 7.854e-05 0.003124
118 REGULATION OF ANATOMICAL STRUCTURE SIZE 21 472 8.53e-05 0.003363
119 MEMBRANE DEPOLARIZATION 7 61 8.694e-05 0.003399
120 BONE DEVELOPMENT 11 156 9.079e-05 0.003491
121 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 19 404 9.011e-05 0.003491
122 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 35 1021 0.0001006 0.003837
123 NEGATIVE REGULATION OF GENE EXPRESSION 46 1493 0.0001039 0.003929
124 POSITIVE REGULATION OF JUN KINASE ACTIVITY 7 63 0.000107 0.004016
125 PROTEIN PHOSPHORYLATION 33 944 0.0001112 0.004139
126 CARDIAC SEPTUM DEVELOPMENT 8 85 0.0001141 0.004186
127 REGULATION OF ION TRANSPORT 24 592 0.0001142 0.004186
128 CENTRAL NERVOUS SYSTEM DEVELOPMENT 31 872 0.0001339 0.004868
129 REGULATION OF RESPIRATORY SYSTEM PROCESS 4 16 0.0001374 0.004957
130 SKELETAL MUSCLE ORGAN DEVELOPMENT 10 137 0.0001419 0.005079
131 SKELETAL SYSTEM DEVELOPMENT 20 455 0.0001474 0.005237
132 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 46 1517 0.0001501 0.005291
133 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 5 30 0.0001523 0.00533
134 CONNECTIVE TISSUE DEVELOPMENT 12 194 0.0001536 0.005334
135 NEGATIVE REGULATION OF PHOSPHORYLATION 19 422 0.0001585 0.005463
136 MORPHOGENESIS OF A BRANCHING STRUCTURE 11 167 0.0001663 0.005689
137 MESONEPHROS DEVELOPMENT 8 90 0.0001705 0.005792
138 ORGAN GROWTH 7 68 0.0001742 0.005811
139 NEGATIVE REGULATION OF CELL DIFFERENTIATION 24 609 0.0001748 0.005811
140 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 6 48 0.0001734 0.005811
141 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 9 116 0.0001921 0.006293
142 REGULATION OF METAL ION TRANSPORT 16 325 0.0001921 0.006293
143 REGULATION OF CELLULAR RESPONSE TO STRESS 26 691 0.0001961 0.006381
144 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 42 1360 0.0002024 0.006539
145 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 7 70 0.0002091 0.00671
146 NEPHRON EPITHELIUM DEVELOPMENT 8 93 0.0002142 0.006734
147 REGULATION OF ION HOMEOSTASIS 12 201 0.0002137 0.006734
148 REGULATION OF BLOOD CIRCULATION 15 295 0.0002142 0.006734
149 NEGATIVE REGULATION OF CELL COMMUNICATION 38 1192 0.0002221 0.006937
150 PLASMA MEMBRANE ORGANIZATION 12 203 0.0002341 0.007262
151 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 5 33 0.0002431 0.007492
152 DIGESTIVE SYSTEM DEVELOPMENT 10 148 0.0002665 0.008105
153 BIOLOGICAL ADHESION 34 1032 0.0002658 0.008105
154 ACTIVATION OF MAPKK ACTIVITY 6 52 0.0002714 0.008201
155 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 5 34 0.000281 0.008329
156 KIDNEY VASCULATURE DEVELOPMENT 4 19 0.0002809 0.008329
157 RENAL SYSTEM VASCULATURE DEVELOPMENT 4 19 0.0002809 0.008329
158 REGULATION OF OSSIFICATION 11 178 0.0002895 0.008526
159 SKELETAL MUSCLE CELL DIFFERENTIATION 6 53 0.0003017 0.008828
160 CELL PART MORPHOGENESIS 24 633 0.0003085 0.008971
161 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 8 99 0.0003292 0.00936
162 POSITIVE REGULATION OF CELL ADHESION 17 376 0.0003319 0.00936
163 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 10 152 0.0003302 0.00936
164 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 8 99 0.0003292 0.00936
165 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 8 99 0.0003292 0.00936
166 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 52 1848 0.0003406 0.009546
167 REGULATION OF NEURON PROJECTION REGENERATION 4 20 0.0003463 0.009649
168 REGULATION OF MEMBRANE POTENTIAL 16 343 0.0003507 0.009714
NumGOOverlapSizeP ValueAdj. P Value
1 KINASE BINDING 31 606 8.708e-08 5.843e-05
2 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 47 1199 1.41e-07 5.843e-05
3 ENZYME BINDING 60 1737 1.887e-07 5.843e-05
4 REGULATORY REGION NUCLEIC ACID BINDING 34 818 2.466e-06 0.0005727
5 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 19 328 5.114e-06 0.0009501
6 IDENTICAL PROTEIN BINDING 43 1209 6.257e-06 0.0009688
7 PROTEIN HOMODIMERIZATION ACTIVITY 30 722 9.958e-06 0.001322
8 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 5 20 1.911e-05 0.002219
9 MAP KINASE KINASE KINASE ACTIVITY 5 22 3.155e-05 0.003257
10 BINDING BRIDGING 12 173 5.143e-05 0.004778
11 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 16 303 8.576e-05 0.006922
12 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 9 105 8.941e-05 0.006922
13 BHLH TRANSCRIPTION FACTOR BINDING 5 28 0.0001081 0.007459
14 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 25 629 0.0001124 0.007459
15 TRANSCRIPTION FACTOR BINDING 22 524 0.0001342 0.008309
16 PROTEIN KINASE ACTIVITY 25 640 0.0001471 0.008538
17 ACTIN BINDING 18 393 0.0001906 0.009717
18 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 8 92 0.0001987 0.009717
19 MACROMOLECULAR COMPLEX BINDING 43 1399 0.0001875 0.009717
20 RECEPTOR SIGNALING PROTEIN ACTIVITY 11 172 0.0002152 0.009997
NumGOOverlapSizeP ValueAdj. P Value
1 MEMBRANE REGION 48 1134 9.635e-09 5.627e-06
2 MEMBRANE MICRODOMAIN 21 288 3.575e-08 1.044e-05
3 PLASMA MEMBRANE RAFT 10 86 2.389e-06 0.0004651
4 ACTIN CYTOSKELETON 22 444 1.136e-05 0.001327
5 CELL JUNCTION 41 1151 1.011e-05 0.001327
6 PLASMA MEMBRANE REGION 35 929 1.48e-05 0.00144
7 BASAL PLASMA MEMBRANE 6 33 1.948e-05 0.001625
8 INTRINSIC COMPONENT OF PLASMA MEMBRANE 51 1649 3.795e-05 0.002771
9 SITE OF POLARIZED GROWTH 11 149 5.995e-05 0.00389
10 VOLTAGE GATED SODIUM CHANNEL COMPLEX 4 14 7.769e-05 0.004125
11 CELL SUBSTRATE JUNCTION 19 398 7.401e-05 0.004125
12 CELL CELL CONTACT ZONE 7 64 0.0001184 0.00494
13 POSTSYNAPSE 18 378 0.0001178 0.00494
14 NEURON PROJECTION 33 942 0.0001069 0.00494
15 ANCHORING JUNCTION 21 489 0.0001395 0.005432
16 SODIUM CHANNEL COMPLEX 4 17 0.0001773 0.00647
17 BASAL PART OF CELL 6 51 0.0002436 0.008369
18 NEURON SPINE 9 121 0.0002639 0.008562
19 BASOLATERAL PLASMA MEMBRANE 12 211 0.0003334 0.009351
20 CONTRACTILE FIBER 12 211 0.0003334 0.009351
21 SARCOLEMMA 9 125 0.0003362 0.009351
22 DENDRITE 19 451 0.0003656 0.009704

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04380_Osteoclast_differentiation 11 128 1.461e-05 0.002629
2 hsa04710_Circadian_rhythm_._mammal 4 23 0.0006075 0.05467
3 hsa04722_Neurotrophin_signaling_pathway 8 127 0.001698 0.0908
4 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 3 15 0.002018 0.0908
5 hsa04115_p53_signaling_pathway 5 69 0.006932 0.1451
6 hsa04010_MAPK_signaling_pathway 11 268 0.007388 0.1451
7 hsa04510_Focal_adhesion 9 200 0.008399 0.1451
8 hsa04014_Ras_signaling_pathway 10 236 0.008428 0.1451
9 hsa04530_Tight_junction 7 133 0.008614 0.1451
10 hsa04151_PI3K_AKT_signaling_pathway 13 351 0.008659 0.1451
11 hsa04144_Endocytosis 9 203 0.00921 0.1451
12 hsa04514_Cell_adhesion_molecules_.CAMs. 7 136 0.009675 0.1451
13 hsa04350_TGF.beta_signaling_pathway 5 85 0.01619 0.2242
14 hsa04630_Jak.STAT_signaling_pathway 7 155 0.01872 0.2406
15 hsa04360_Axon_guidance 6 130 0.02598 0.3118
16 hsa00770_Pantothenate_and_CoA_biosynthesis 2 16 0.03068 0.3452
17 hsa04672_Intestinal_immune_network_for_IgA_production 3 49 0.05312 0.5519
18 hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate 2 22 0.05519 0.5519
19 hsa00512_Mucin_type_O.Glycan_biosynthesis 2 30 0.09505 0.9005
20 hsa04620_Toll.like_receptor_signaling_pathway 4 102 0.1017 0.9152
21 hsa04920_Adipocytokine_signaling_pathway 3 68 0.1143 0.9709
22 hsa04660_T_cell_receptor_signaling_pathway 4 108 0.1187 0.9709
23 hsa04390_Hippo_signaling_pathway 5 154 0.1305 0.9764
24 hsa04520_Adherens_junction 3 73 0.1335 0.9764
25 hsa04145_Phagosome 5 156 0.1356 0.9764
26 hsa00310_Lysine_degradation 2 44 0.1773 1
27 hsa04973_Carbohydrate_digestion_and_absorption 2 44 0.1773 1
28 hsa04110_Cell_cycle 4 128 0.1829 1
29 hsa04512_ECM.receptor_interaction 3 85 0.1834 1
30 hsa04012_ErbB_signaling_pathway 3 87 0.1922 1
31 hsa00983_Drug_metabolism_._other_enzymes 2 52 0.2279 1
32 hsa04912_GnRH_signaling_pathway 3 101 0.2559 1
33 hsa04670_Leukocyte_transendothelial_migration 3 117 0.3315 1
34 hsa03018_RNA_degradation 2 71 0.3497 1
35 hsa04020_Calcium_signaling_pathway 4 177 0.3688 1
36 hsa04664_Fc_epsilon_RI_signaling_pathway 2 79 0.3994 1
37 hsa03008_Ribosome_biogenesis_in_eukaryotes 2 81 0.4115 1
38 hsa04974_Protein_digestion_and_absorption 2 81 0.4115 1
39 hsa04062_Chemokine_signaling_pathway 4 189 0.4159 1
40 hsa04650_Natural_killer_cell_mediated_cytotoxicity 3 136 0.4208 1
41 hsa04910_Insulin_signaling_pathway 3 138 0.43 1
42 hsa04914_Progesterone.mediated_oocyte_maturation 2 87 0.4472 1
43 hsa04640_Hematopoietic_cell_lineage 2 88 0.453 1
44 hsa04210_Apoptosis 2 89 0.4588 1
45 hsa04970_Salivary_secretion 2 89 0.4588 1
46 hsa00240_Pyrimidine_metabolism 2 99 0.5147 1
47 hsa04972_Pancreatic_secretion 2 101 0.5254 1
48 hsa00230_Purine_metabolism 3 162 0.5356 1
49 hsa04114_Oocyte_meiosis 2 114 0.5911 1
50 hsa04270_Vascular_smooth_muscle_contraction 2 116 0.6006 1
51 hsa04120_Ubiquitin_mediated_proteolysis 2 139 0.6978 1
52 hsa04810_Regulation_of_actin_cytoskeleton 3 214 0.7208 1
53 hsa04141_Protein_processing_in_endoplasmic_reticulum 2 168 0.7917 1

Quest ID: 17b790459e1857515ad16d9d8eb28ff6